Zai Lab Limited Stock OTC Markets
Stocks
ZAIL.F
KYG9887T1168
Pharmaceuticals
OTC Markets Traded| Market Cap | 2.15B 1.88B 1.73B 1.61B 3.05B 205B 3.11B 20.78B 8.05B 100B 8.07B 7.89B 346B | P/E 2026 * |
-8.63x | P/E 2027 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.71B 1.49B 1.37B 1.28B 2.42B 163B 2.46B 16.5B 6.39B 79.67B 6.4B 6.26B 275B | EV / Sales 2026 * |
3.8x | EV / Sales 2027 * | 2.96x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 60 | 2014-03-31 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 2023-07-06 |
Rafael Amado
PSD | President | 62 | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 60 | 2014-03-31 |
John Diekman
BRD | Director/Board Member | 82 | 2016-12-31 |
Peter Wirth
BRD | Director/Board Member | 74 | 2016-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.15B | |
| +4.73% | +4.95% | +22.31% | -8.94% | 63.56B | |
| +2.60% | +3.76% | +58.59% | +225.86% | 55.92B | |
| +0.72% | +40.60% | +40.60% | +40.60% | 41.68B | |
| -0.52% | +2.40% | -50.58% | -57.55% | 39.12B | |
| +3.04% | +8.28% | +66.16% | -24.13% | 30.97B | |
| +10.01% | +32.01% | +178.01% | -34.35% | 28.77B | |
| +2.68% | +7.74% | +70.03% | +87.73% | 22.74B | |
| +7.22% | +9.49% | +8.86% | +188.34% | 17.64B | |
| +2.43% | +1.78% | +68.16% | +127.95% | 16.66B | |
| Average | +2.24% | +5.12% | +51.35% | +60.61% | 35.23B | |
| Weighted average by Cap. | +2.39% | +4.34% | +45.61% | +54.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 449M 393M 361M 336M 636M 42.8B 649M 4.34B 1.68B 20.97B 1.68B 1.65B 72.35B | 596M 521M 479M 446M 845M 56.81B 861M 5.76B 2.23B 27.83B 2.24B 2.19B 96.03B |
| Net income | -241M -211M -194M -181M -342M -22.98B -348M -2.33B -903M -11.26B -904M -885M -38.84B | -156M -137M -126M -117M -222M -14.92B -226M -1.51B -587M -7.31B -587M -575M -25.23B |
| Net Debt | -443M -388M -356M -332M -628M -42.27B -641M -4.29B -1.66B -20.71B -1.66B -1.63B -71.45B | -387M -339M -311M -290M -549M -36.93B -560M -3.75B -1.45B -18.09B -1.45B -1.42B -62.43B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
